FEB. 13, 2017 - 5 REASONS ISRAEL IS DOMINATING THE CANNABIS INDUSTRY
In January this year, the
government announced it is investing $2.13 million in 13 research
projects including the effect of cannabis on metabolic syndrome, MS,
preventing transplanted organ rejection, and inhibiting the
development of harmful bacteria.
2. Genetic Engineering
GMO may have a negative
implication in food, but when it comes to medical marijuana, genetic
engineering is deemed crucial for treating a range of diseases.
technologies are being adapted to the marijuana crop, while new
technologies are geared specifically to this healing plant.
regularly join forces with Israeli academic and medical institutions
to create new medications.
For example, Kalytera
Therapeutics, a US company developing a new class of proprietary
cannabidiol (CBD) therapeutics, recently licensed two synthetic
cannabis derivatives from the Hebrew University’s technology
transfer company Yissum, for eventual use in treating osteoporosis,
bone fractures and other diseases.
5. Medical Devices
Once the cannabis has
been grown, extracted and formulated, it needs a delivery system for
proper dosage — a tablet, a patch, a nasal spray or a cigarette,
for example. And that’s where Israeli ingenuity comes in.
Late last year, Teva
Pharmaceutical Industries agreed to market medical cannabis for
pain management in Israel with a revolutionary selective-dose
pharmaceutical-grade medicinal plants inhaler from Tel Aviv-based
company Cannabics Pharmaceuticals is working to put the
medicinal compounds of cannabis into a sustained-release capsule
in standardized doses.